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Introduction
Hepatitis B Virus (HBV) is a major coinfection in HIV
infected patients and it has emerged as an important
cause of morbidity and mortality in this group since the
start of Highly Active Antiretroviral Therapy (HAART).
HIV/HBV coinfection prevalence varies by geographic
r e g i o ne v e nw i t h i nt h es a m ec o u n t r y .I nB o t s w a n at h e
c o i n f e c t i o np r e v a l e n c ed a t ai sv e r ys p a r s ea n dw h a ti s
reported varies. Ten HBV genotypes with some subgeno-
types have been described differing by geographic distri-
bution, course of disease, response to treatment and
development of mutations. Even though data have shown
that genotypes are predictive of disease outcome, the cir-
culating HBV genotypes in Botswana remains unknown.
Therefore this study aims at determining the HIV\HBV
coinfection prevalence rate and the circulating HBV gen-
otypes in Botswana.
Materials and methods
This is a retrospective cross sectional study of HIV indivi-
duals initiating HAART. Hepatitis B surface antigen
(HBsAg) was screened for in 300 baseline samples and
those which were positive were also screened for HBeAg.
For the HbsAg positive a 415 bp fragment of the HBV
polymerase gene was sequenced using Big Dye sequencing
chemistry and the sequences were analyzed for genotypes
and mutations.
Results
Of the 300 participants, 28(9.3%) were HBsAg positive
and 5(17.9%) were HBeAg positive. Of the 27 samples
that were successfully genotyped, genotype A was found
in 23 (85.2%), 22 subgenotype A1 and 1 subgenotypeA2,
genotype D subgenotype D3 made up the remaining 4
(14.8%). Known escape mutations were found in 12
(44.4%) with the most common one being N131N found
in 8(29.6%) of the participants. The other escape muta-
tions were R122K, T123A, Q129R, G130N, M133T and
F134V.No drug resistance mutations were detected.
Conclusion
The HIV/HBV prevalence is consistent with what has
been reported in the country. The predominant genotype
in this cohort is A1 and its consistent with findings from
the region. Escape mutations previously associated with
failure of HBsAg detection and vaccine or immunoglo-
blin therapy were found in a significant number of parti-
cipants. No known drug resistance mutations were found
in the cohort.
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